Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Heterodimeric Glucuronide Prodrug for Cancer Tritherapy: the Double Role of the Chemical Amplifier

3 Aug 2011

Abstract excerpt

Amplified action! We developed the therapeutic first targeting system that includes a chemical amplifier programmed both to release two potent anticancer drugs after a single enzymatic activation step and become cytotoxic itself once the amplification process is completed.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Peptidase Inhibition and Analysis
Share to Signaling Pathways in Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21815268
DOI: 10.1002/cmdc.201100355

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Heterodimeric Glucuronide Prodrug for Cancer Tritherapy: the Double Role of the Chemical AmplifierPMID 21815268Read ↗

An overview of targeted cancer therapySemantic proximity Read ↗

Review of the Fluoropyrimidine Antidote Uridine TriacetateSemantic proximity Read ↗

Enzyme activity as an actionable axis for small-molecule precision oncologySemantic proximity Read ↗

Systemic tumor-targeting gene drive vectors proactively eliminate drug resistance in solid tumorsSemantic proximity Read ↗

Recent progress of aptamer‒drug conjugates in cancer therapySemantic proximity Read ↗

Annexin-directed β-glucuronidase for the targeted treatment of solid tumors.Semantic proximity Read ↗

Biodistribution-Driven Discovery Identifies a Glycosidase-Cleavable Linker to Reprogram RadiotheranosticsSemantic proximity Read ↗

Dual advantages of SN38 prodrug nanoassemblies overcome defects of irinotecan and SN38: enhanced stability and activatabilitySemantic proximity Read ↗

STING-Activating Polymer-Drug Conjugates for Cancer ImmunotherapySemantic proximity Read ↗

Antibody-mediated co-delivery of programmable drug combinationsSemantic proximity Read ↗

Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer.Semantic proximity Read ↗

Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.